Menu Search
Equities

Uniphar PLC

UPR:LSE

Uniphar PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)188.00
  • Today's Change0.00 / 0.00%
  • Shares traded4.00
  • 1 Year change-4.57%
  • Beta--
Data delayed at least 20 minutes, as of Nov 07 2024 09:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Uniphar PLC is an Ireland-based diversified healthcare service company. The Company is focused on improving access to pharmaco-medical products and therapies. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through its on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare and animal health products to pharmacies, hospitals and veterinary surgeons in Ireland. It operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. It also provides services and support that help independent community pharmacies.

  • Revenue in EUR (TTM)2.68bn
  • Net income in EUR45.17m
  • Incorporated1994
  • Employees3.26k
  • Location
    Uniphar PLC4045 Kingswood DriveCitywest Business ParkDUBLIN D24 VO6KIrelandIRL
  • Phone+353 14287777
  • Fax+353 14287776
  • Websitehttps://www.uniphar.ie/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.